Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently,
a strong relationship between serum TSH and risk of thyroid malignancy has been reported …

The risk of papillary thyroid cancer (PTC) is related to serum TSH, and the development of
thyroid autonomy by reducing TSH levels decreases the frequency of PTC in patients with …

Higher TSH values, even within normal ranges, have been associated with a greater risk of
thyroid malignancy. The relationship between TSH and papillary thyroid cancer (PTC) has …

Objectives Higher thyroid‐stimulating hormone (TSH) levels are associated with
differentiated thyroid cancers (DTC). To validate this association, we compared TSH levels …

There is mounting evidence that the serum concentration of TSH is an independent predictor
for the diagnosis of thyroid malignancy in patients with nodular thyroid disease. Furthermore …

Background It has previously been shown that higher serum TSH is associated with
increased thyroid cancer incidence and advanced‐stage disease. In the healthy adult …

Background The role of serum TSH concentrations as a predictor of malignancy of thyroid
nodule remains unclear. Objective To prospectively evaluate the usefulness of serum TSH …

Context: TSH is the major growth factor for thyrocytes and may have a causative role in
thyroid cancer. Objective: The objective of the study was to systematically assess the …

Context: TSH is a known thyroid growth factor, but the pathogenic role of TSH in thyroid
oncogenesis is unclear. Objective: The aim was to examine the relationship between …

Purpose Serum thyrotropin (TSH) is a well-established growth factor for thyroid nodules and
suppression of TSH concentrations by administering exogenous thyroxine may interfere with …